Li Ming, Wang Rui, Xiang Hua
State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China University of Chinese Academy of Sciences, Beijing 100049, China.
State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
Nucleic Acids Res. 2014 Jun;42(11):7226-35. doi: 10.1093/nar/gku389. Epub 2014 May 6.
The prokaryotic immune system CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated genes) adapts to foreign invaders by acquiring their short deoxyribonucleic acid (DNA) fragments as spacers, which guide subsequent interference to foreign nucleic acids based on sequence matching. The adaptation mechanism avoiding acquiring 'self' DNA fragments is poorly understood. In Haloarcula hispanica, we previously showed that CRISPR adaptation requires being primed by a pre-existing spacer partially matching the invader DNA. Here, we further demonstrate that flanking a fully-matched target sequence, a functional PAM (protospacer adjacent motif) is still required to prime adaptation. Interestingly, interference utilizes only four PAM sequences, whereas adaptation-priming tolerates as many as 23 PAM sequences. This relaxed PAM selectivity explains how adaptation-priming maximizes its tolerance of PAM mutations (that escape interference) while avoiding mis-targeting the spacer DNA within CRISPR locus. We propose that the primed adaptation, which hitches and cooperates with the interference pathway, distinguishes target from non-target by CRISPR ribonucleic acid guidance and PAM recognition.
原核生物免疫系统CRISPR/Cas(成簇规律间隔短回文重复序列/CRISPR相关基因)通过获取外来入侵者的短脱氧核糖核酸(DNA)片段作为间隔序列来适应外来入侵者,这些间隔序列基于序列匹配指导对外来核酸的后续干扰。避免获取“自身”DNA片段的适应机制目前还知之甚少。在西班牙嗜盐菌中,我们之前表明CRISPR适应需要由与入侵者DNA部分匹配的预先存在的间隔序列引发。在这里,我们进一步证明,在完全匹配的靶序列侧翼,仍然需要一个功能性的原间隔序列临近基序(PAM)来引发适应。有趣的是,干扰仅利用四种PAM序列,而适应引发则容忍多达23种PAM序列。这种宽松的PAM选择性解释了适应引发如何在避免错误靶向CRISPR位点内的间隔DNA的同时,最大化其对PAM突变(逃避干扰)的耐受性。我们提出,与干扰途径搭便车并合作的引发适应,通过CRISPR核糖核酸引导和PAM识别来区分靶标和非靶标。